Edition:
United States

Bayer AG (BAYRY.PK)

BAYRY.PK on OTC Markets Group

110.58USD
27 Feb 2017
Change (% chg)

$-0.16 (-0.14%)
Prev Close
$110.74
Open
$110.81
Day's High
$111.28
Day's Low
$110.45
Volume
74,260
Avg. Vol
131,620
52-wk High
$125.20
52-wk Low
$91.53

Select another date:
Photo

Bayer sells 11 percent of Covestro for 1.46 billion euros

FRANKFURT Drugmaker Bayer has sold 1.46 billion euros ($1.5 billion) of shares in its chemicals subsidiary Covestro , cutting its stake to 53.3 percent as it raises cash for its takeover of seeds maker Monsanto .

Covestro CFO says any sale to industry player not off the table

FRANKFURT Bayer's sale of an 11 percent stake in chemicals subsidiary Covestro on the open market would not prevent the parent company from considering any takeover offers from industry players, Covestro's finance chief told Reuters.

Covestro CFO says any sale to industry player not off the table

FRANKFURT, March 1 Bayer's sale of an 11 percent stake in chemicals subsidiary Covestro on the open market would not prevent the parent company from considering any takeover offers from industry players, Covestro's finance chief told Reuters.

BRIEF-Bayer places Covestro shares at 66.50 euros apiece

* Says has reduced its holding in Covestro from 64.2 percent to 53.3 percent

Covestro priced at 66.50 euros/share in Bayer sell-down -source

FRANKFURT, Feb 28 Bayer has placed shares in separately listed chemicals subsidiary Covestro at 66.50 euros apiece, a source close to the matter said.

Bayer cuts Covestro stake in open market transaction

FRANKFURT, Feb 28 Bayer said on Tuesday it was reducing its stake in separately listed chemicals subsidiary Covestro in an accelerated bookbuilding process as it seeks to secure funding for the $66 billion takeover of seeds maker Monsanto.

Supreme Court lets Bayer proceed with Flanax lawsuit

The U.S. Supreme Court on Monday refused to dismiss an unfair competition lawsuit by two units of German pharmaceutical giant Bayer against a Virginia company that sells the painkiller Flanax in the U.S.

BRIEF-Bayer confident it will receive CFIUS approval for Monsanto takeover

* Ceo says assume that we will receive cfius approval for monsanto takeover Further company coverage: (Frankfurt newsroom)

Bayer sees pesticides profits stagnating before Monsanto takeover

LEVERKUSEN, Germany German drugs and pesticides maker Bayer forecast a year without earnings growth for its agricultural products business on Wednesday, as it seeks to complete its $66 billion deal to take over U.S. seeds giant Monsanto .

UPDATE 2-Bayer sees pesticides profits stagnating before Monsanto takeover

* Aims for mid 1-digit pct gain in 2017 adj group EBITDA (Adds quote from divisional head, shares, update on EU antitrust scrutiny)

Select another date:

More From Around the Web